Abstract
Bone marrow transplantation provides an important modality for “enzyme replacement” and the immune reconstitution of patients with adenosine deaminase (ADA) deficiency and severe combined immunodeficiency disease. We report a patient with ADA deficiency who develops severe varicella pneumonia 6 years after successful bone marrow transplantation and immune reconstitution. Marked abnormalities in T-cell mitogen responsiveness and pokeweed mitogen-induced polyclonal immunoglobulin synthesis occurred. Coculture experiments suggested the presence of increased suppressor activity. T-cell phenotyping showed decreased T3 and T4 subsets. These abnormalities slowly resolved over several months as the patient recovered from the varicella infection. ADA enzyme levels and metabolite concentrations in urine and erythrocytes remained unchanged. These findings, together with the chromosome and immune studies, suggested that the bone marrow graft remained intact. These studies indicate that immunologically reconstituted ADA-deficient patients may be at higher risk for complications related to varicella infection and suggest that the institution of preventive measures is important.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Horowitz SD, Hong R: Pathogenesis and treatment of immunodeficiency.In Monographs in Allergy, Vol 10. New York, Karger, 1977, pp 77–133
Bortin MM, Rimm AA: Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. JAMA 238:591–600, 1977
Gatti RA, Allen HD, Meuwissen HJ,et al.: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366–1368, 1968
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ: Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067–1069, 1972
Meuwissen HJ, Pollara B, Pickering RJ: Combined immunodeficiency disease associated with adenosine deaminase deficiency. J Pediat 86:169–181, 1975
Hirschhorn R: Defects of purine metabolism in immunodeficiency diseases.In Progress in Clinical Immunology, RS Schwartz (ed). New York, Grune & Stratton, 1977, Vol III, pp 67–83
Schmalstieg FC, Nelson JA, Mills GC, Monahan TM, Goldman AS, Goldblum RM: Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J Pediat 9:48–51, 1977
Simmonds HA, Sahota A, Potter CF, Cameron JS: Purine metabolism and immunodeficiency: Urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency. Clin Sci Mol Med 54:579–584, 1978
Cohen AR, Hirschhorn R, Horowitz SD, Rubinstein A, Polmar SH, Hong R, Martin DW Jr: Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deficiency. Proc Natl Acad Sci USA 75:472–476, 1978
Donofrio J, Coleman MS, Hutton JJ: Overproduction of adenine deoxynucleosides and deoxynucleotides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Clin Invest 62:884–887, 1978
Hirschhorn R, Roegner-Maniscalco V, Kuritsky L, Rosen FS: Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J Clin Invest 68:1387–1393, 1981
Chen SH, Ochs HD, Scott CR, Giblett ER, Tingle AJ: Adenosine deaminase deficiency-disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation. J Clin Invest 62:1386–1389, 1978
Polmar SH, Stern RC, Schwartz AL, Wetzler EM, Chase PA, Hirschhorn R: Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med 295:1337–1343, 1976
Ballow M, McLean RH, Damjanov I, Lowenstein MB: Immunologic reconstitution, autoimmunity, and T-cell immune deficiencies. Cell Immunol 45:364–376, 1979
Lindsten T, Seeley JK, Ballow M, Sakamoto K, St Onge S, Yetz J, Aman P, Purtilo DT: Immune deficiency in the x-linked lymphoproliferative syndrome: Immunoregulatory T cell defects. J Immunol 129:2536–2540, 1982
Hirschhorn R, Roegner V, Jenkins T, Seaman C, Piomelli S, Borkowsky W: Erythrocyte adenosine deaminase deficiency without immunodeficiency: Evidence for an unstable mutant enzyme. J Clin Invest 64:1130–1139, 1979
Coleman MS, Hutton JJ: Micromethod for quantitation of adenosine deaminase activity in cells from human peripheral blood. Biochem Med 13:46–55, 1975
Hirschhorn R, Ratech H, Rubinstein A, Papageorgiou P, Kesarwala H, Gelfand E, Roegner-Maniscalco V: Increased excretion of modified adenine nucleosides by children with adenosine deaminase deficiency. Pediat Res 16:362–369, 1982
Wolberg G, Zimmerman TP, Hemstra K, Winston M, Chu LC: Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate. Science 187:957–959, 1975
Hershfield MS, Kredich NM, Ownby DR, Ownby H, Buckley R: In vivo inactivation of erythrocyte s-adenosyl homocysteine hydrolase in adenosine deaminase-deficient patients. J Clin Invest 63:807–811, 1979
Schwartz AL, Stern RC, Polmar SH: Demonstration of an adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency. Clin Immunol Immunopathol 9:499–505, 1978
Parkman R, Gelfand EW, Rosen FS, Sanderson A, Hirschhorn R: Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 292:714–719, 1975
Bullowa JGM, Wishik SM: Complication of varicella. Am J Dis Child 49:923, 1935
Bertotto A, Gentili F, Vaccaro R: Immunoregulatory T cells in varicella. N Engl J Med 307:1271–1272, 1982
Kumagai T, Chiba Y, Wataya Y, Hanazono H, Chiba S, Nakao T: Development and characteristics of the cellular immune response to infection with varicella-zoster virus. J Infect Dis 141:7–13, 1980
Arneborn P, Biberfeld G: T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun 39:29–37, 1983
Crawford DH, Brickell P, Tidman N, McConnell I, Hoffbrand AV, Janossy G: Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol 43:291–297, 1981
DeWaele M, Thielemans C, Van Camp BKG: Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N Engl J Med 304:460–462, 1981
Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF: The cellular basis for viral-induced immunodeficiency: Analysis by monoclonal antibodies. J Immunol 125:1269–1274, 1980
Carney WP, Rubin RH, Hoffman RA, Hansen WP, Healy K, Hirsch MS: Analysis of T-lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 126:2114–2116, 1981
Thomas HC: T-cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease. Int J Immunopharmacol 3:301–305, 1981
Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good RA, O'Reilly RJ: Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341–348, 1983
Good RA, Kapoor N, Reisner Y: Bone marrow transplantation—an expanding approach to treatment of many diseases. Cell Immunol 82:36–54, 1983
Bortin MM: International Bone Marrow Transplant Registry,3 1984
Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB, Scolnick EM: Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 310:1409–1415, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ballow, M., Hirschhorn, R. Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease. J Clin Immunol 5, 180–186 (1985). https://doi.org/10.1007/BF00915509
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915509